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The aim of this study was to check non-invasively the acute haemodynamic effects of non-invasive positive pressure 
ventilation (NPPV) initiation in patients with chronic obstructive pulmonary disease (COPD) and acute ventilatory 
failure (AVF). Nineteen consecutive COPD patients with AVF were evaluated clinically and echocardiographically 
during spontaneous breathing with 0, supplementation and during NPPV plus 0,. NPPV was administered with a 
scheduled inspiratory pressure of 15 cmH,O and an expiratory pressure of 4 cmH,O, via facial mask. Arterial blood 
gas improved significantly (pH and PaCO,; P<O.OOl) during NPPV administration in all patients; none had 
hypotension or acute arrhythmia. Doppler echocardiographic evaluation was feasible in most of the patients (16/l 8). 
With reference to baseline values, no significant changes in pulmonary artery pressures and cardiac output (CO) 
were observed by Doppler echocardiography in most patients. Only four patients (21%) showed a significant 
reduction (> 15%) of CO during NPPV. No correlation was found between decreased CO and baseline data, but 
three patients showing CO reduction had poor tolerance to mask ventilation and did not improve respiratory rate 
during NPPV. It was concluded that the initiation of NPPV by facial mask does not alter haemodynamics acutely 
in most COPD patients with AVF, but individual patients may experience reduction in CO in spite of adequate 
oxygen saturation levels. This suggests that caution should be used when applying pre-determined and fixed 
pressures during NPPV. Monitoring haemodynamics by Doppler echocardiography may be useful for early 
detection of haemodynamic alterations due to NPPV application in patients with AVF. 
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Introduction 
Recent, prospective, randomized trials (l-3) have clearly 
established non-invasive positive pressure ventilation 
(NPPV) by nasal or facial mask as a first-line treatment in 
selected patients with acute ventilatory failure (AVF) due to 
exacerbation of chronic obstructive pulmonary disease 
(COPD). In the last few years, a number of controlled and 
uncontrolled studies, involving more than 500 patients, 
have appeared in the literature (4), demonstrating very low 
complication rates associated with NPPV. Moreover, no 
report exists to date on NPPV-related haemodynamic com- 
plications in COPD patients with AVF in the literature, 
Conversely, it is well known that invasive mechanical 
ventilation may seriously alter haemodynamic status by 
decreasing cardiac output and modifying blood flow distri- 
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bution (5). The intubation and initiation of positive pres- 
sure ventilation in acute exacerbation of COPD (6) is one of 
the clinical settings which is most likely to trigger haemo- 
dynamic compromise. In theory, relatively low support 
pressures, together with the absence of neuromuscular 
blockade and sedation, should produce a lower impact of 
NPPV on haemodynamics. The aim of this study is to 
assess whether or not the initiation of NPPV by face mask 
with scheduled inspiratory and expiratory positive pres- 
sures can acutely modify haemodynamic status in COPD 
patients with AVF. For this purpose, we used colour 
Doppler echocardiography, a non-invasive technique 
suitable for haemodynamics evaluation in ventilated and 
COPD patients (7-9). 
Methods 
SUBJECTS 
We studied 19 COPD patients (14 males and five females, 
mean age 67 f 9 years) who were admitted for management 
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of decompensated AVF. COPD diagnosis was confirmed 
by patient history and physical examination as well as by 
previous pulmonary function tests. Patients were consid- 
ered eligible for the study if they conformed with the 
following criteria: 
l respiratory acidosis and AVF (at least two of the follow- 
ing blood gas values: pH ~7.30, PaCO, >7.90 kPa, PaO, 
~7.98 kPa) due to exacerbation of COPD; 
l absence of coma; 
l absence of haemodynamic instability (uncontrolled 
cardiac arrhythmias and/or systolic blood pressure 
~90 mmHg). 
An illness-severity score, simplified acute physiologic 
score (SAPS) (lo), and a neurological score, specifically 
designed for respiratory patients by Kelly and Matthay 
(1 l), were determined for each patient at study entry. 
PROTOCOL 
At hospital admission, each patient received oxygen supple- 
mentation and aerosolized salbutamol (1.25 mg) and ip- 
atropium bromide (0.25 mg) plus beclomethasone (40 mg) 
in an emergency room setting. After 15-20 min, patients 
were transferred to the respiratory intermediate intensive 
care unit (RIICU), for NPPV plus 0, therapy. Patients 
received 0, therapy alone for almost 30 min altogether. 
NPPV was begun with 0, supplementation adjusted to give 
an arterial 0, saturation of 90-92%. Patients were sequen- 
tially evaluated clinically (including non-invasive blood 
pressure) and echocardiographically during 0, supplemen- 
tation at RIICU admission (after 30 min of oxygen 
supplementation) and during NPPV plus 0, after a 30 min 
lapse. Randomization of treatment order was not per- 
formed since (a) emergency room, acute respiratory distress 
patients routinely receive oxygen supplementation before 
a medical visit, (b) no acute haemodynamic changes in 
exacerbated COPD and acute respiratory failure patients 
treated with oxygen supplementation have been reported to 
date (12-14) and lastly (c) we wished to avoid the hysteretic 
effect caused by positive pressure ventilation (15). Particu- 
lar care in patient timing management was performed to 
guarantee from the lack of random order in NPPV appli- 
cation (16). Also, echocardiograph personnel were not 
aware of the background or aim of the study at the time of 
Doppler measurements. Furthermore, ethical concerns pro- 
hibited baseline evaluation of patients breathing without 
oxygen supplementation and the inclusion of a non- 
ventilated control group. Informed consent was given by 
the patients or next of kin. The study was approved by the 
Local Ethics Committee. 
NON-INVASIVE VENTILATION 
NPPV was delivered by a bi-level positive airway pressure 
(BiPAPa S/T-D, Respironics Inc, Murrisville, PA, U.S.A.) 
through a facial mask (Gibeck Respiration AB, Upplands- 
V&by, Sweden). BiPAP (17 is a flow-triggered device 
working as a pressure support (PSV) which can apply 
external positive end-expiratory pressure (PEEP). We 
applied BiPAP in spontaneous mode with a scheduled 
inspiratory pressure support of lScmH,O and an expira- 
tory positive pressure of 4 cmH,O. We chose these pressure 
levels based on our clinical experiences of NPPV efficacy 
(18,19) and on the reported experiences of other authors 
(20-23). A pneumologist assisted to facilitate patient 
co-operation at all times. The mask cushion was inflated 
with about 20 ml of air for perfect adherence to the 
patient’s face and particular care was taken to avoid 
possible air leaks. Before and during NPPV application, 
oxygen was administered at the lowest flow to provide an 
arterial oxygen saturation of 90-92% under oxymetric 
control (Pulsox 7, Minolta, Avl AG, Switzerland). Patient 
compliance with ventilation was evaluated by the physician 
in charge. 
ECHOCARDIOGRAPHIC MEASUREMENTS 
Two-dimensional, continuous wave (CW), pulsed-wave and 
colour Doppler echocardiography (Hewlett-Packard 
77020A, ultrasound imaging system, Andover, MA, 
U.S.A.) was performed using 2.5 MHz imaging trans- 
ducers. Doppler recordings of tricuspid regurgitation 
velocity and pulmonary flow were attempted from para- 
sternal, apical and subcostal approaches. The ‘contrast- 
enhancement’ technique (agitated isotonic saline i.v. 
injections) was used in selected patients to increase the 
quality of CW Doppler tracings (24). Maximum velocity of 
tricuspid regurgitation ‘jet (TR) was measured by CW 
Doppler imaging. The simplified Bernoulli equation was 
used to calculate the systolic transtricuspid gradient 
which was added to mean right atria1 pressure (clinically 
estimated) to predict pulmonary artery systolic pressure 
(PASP), according to a validated technique (25). The pulsed 
Doppler technique was used to study pulmonary artery 
systolic flow velocity, as described by Kitabatake et al. (26). 
Acceleration time (ACT) was defined as the interval between 
the onset of ejection and peak flow velocity. Right 
ventricular ejection fraction time (RVET) was defined as 
the interval between ejection onset to zero flow velocity. We 
also used the regression equation proposed by Mahan et al. 
(27), which involves ACT, to predict pulmonary artery mean 
pressure (PAMP). 
Blood flow velocity through the aortic valve was assessed 
by pulsed Doppler echocardiography using a suprasternal 
approach. Cardiac output (CO) was calculated as the 
product of the cross-sectional area of the aorta, aortic flow 
velocity integral and heart rate. Cardiac index (CI) was 
derived by dividing CO by body surface area. This standard 
method was extensively validated and used also in COPD 
patients (28-30). Two-dimensional echocardiographic data, 
as such the end-diastolic right ventricular:left ventricular 
dimensions ratio (RVEDD:LVEDD), even though they 
are useful in a clinical setting (31), were not considered 
because they are not validated and difficult to obtain in 
hyperinflated patients. 
Since the spontaneous variability of pulmonary artery 
pressure in COPD patients at rest has a coefficient of 
TABLE 1. Patients’ characteristics at hospital admission 
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Mean Oedema Baseline? 
Patient Age BP PaO, PaCO, of the RR HR Kelly FEVJFVC 
no. (years) Sex (mmHg) (kPa) (kPa) pH legs (breaths min - ‘) (beats min - ‘) score* SAPS wo) 
1 12 M 133 
2 64 M 106 
3 13 M 83 
4 64 M 97 
5 51 F 102 
6 78 M 110 
I 59 M 170 
8 15 M 111 
9 58 M 100 
10 73 M 103 
11 78 M 113 
12 72 M 123 
13 67 F 150 
14 85 F 93 
15 72 F 93 
16 56 M 106 
17 72 M 93 
18 65 F 93 
19 54 M 85 
Mean 67.7 = 108.6 
SD 9.14 = 22.11 
SE 2.1 = 5.07 
5.18 11.7 7.28 = 
7.18 7.84 7.35 = 
4.78 10.26 7.29 +++ 
6.46 9.56 7.34 + 
5.98 11.71 7.17 = 
4.65 10.1 7.19 ++ 
4.89 10.2 7.28 +++ 
7.71 9.5 7.17 ? 
4.65 13.73 6.99 + 
4.42 13.75 7.15 = 
6.38 11.67 7.22 = 
6.38 9.84 7.31 +++ 
4.78 7.71 7.25 = 
5.85 11.17 7.19 = 
5.18 9.94 7.32 + 
6.25 9.27 7.21 = 
6.11 9.94 7.32 ++ 
5.18 9.84 7.29 = 
6.51 8.15 7.33 = 
5.7 10.25 7.25 = 
0.9 1.76 0.09 = 
0.2 0.38 0.02 = 
28 88 
26 96 
32 102 
28 75 
30 118 
30 120 
38 90 
36 120 
40 122 
48 99 
34 110 
32 115 
32 108 
12 130 
28 100 
27 96 
30 100 
30 90 
22 100 
30.6 100.1 
7.3 14.09 
1.6 3.23 
2 13 
1 6 
3 18 
1 8 
2 12 
3 16 
2 17 
2 14 
3 13 
2 11 
2 15 
2 17 
1 11 
3 10 
3 9 
1 4 
1 5 
2 8 
1 6 
2 11.2 
0.8 4.3 
0.2 0.9 
40 
31 
48 
38 
36 
? 
29 
35 
37 
36 
33 
30 
46 
3 
45 
34 
40 
33 
38 
37 
5.49 
1.33 
*Neurological score by Kelly and Matthay to assess neurological status in patients with acute respiratory failure (11). 
tThe latest available data before hospital admission. 
variation up to lo-6% (32) and since cardiac output 
measured by echocardiography shows a variability up to 
12% (33) we decided that echo Doppler parameter vari- 
ations of 15% or more would be considered significantly 
relevant. 
REPEATABILITY OF ECHOCARDIOGRAPHIC 
MEASUREMENTS 
Doppler echocardiography was performed by two trained 
cardiologists from two different institutions. Validation of 
echocardiograph measurements was previously described 
by others with regard to CO and PAP (25,30). Repeatability 
of the technique by the two observers, blinded to each 
other’s results, was previously carried out for eight subjects 
(four COPD and four healthy subjects; five males; mean age 
61<8 years) according to the methodology proposed by 
Bland and Altman (34). 
STATISTICAL ANALYSIS 
Individual data and mean & SD and SE are presented in the 
tables. Since the data conform with a normal distribution, 
statistical analysis for values obtained before and during 
NPPV were performed by paired Student’s t testing with 
Bonferonni’s adjustment. A linear regression analysis was 
used to search for a correlation between haemodynamic 
and respiratory-clinical data. Statistical significance was 
defined as PcO.05. 
Results 
Baseline characteristics of patients at admission are shown 
in Table 1. Study population showed, as a whole, pulmon- 
ary hypertension and a mild increase of CO. Heart rate 
(P=O.265), systolic and mean systemic blood pressures 
(respectively PxO.054 and P=O.134), systolic PAP 
(P=O.O63), mean PAP (P=O.298), cardiac output 
(P=O.829) and cardiac index (P=O.851) did not change 
significantly during the application of BiPAP through a 
face mask in the study population considered as a whole. 
After 30 min of NPPV application, no significant changes 
were observed in PaO, values when compared with PaO, 
following oxygen therapy alone. On the contrary, signifi- 
cant differences were found between pH, PaCO, and RR 
assessed during 0, therapy alone and during NPPV (Table 
2). Table 2 shows the results of echocardiograph evalu- 
ations (mean f SD). Most of the 19 acute COPD patients 
did not have significant changes in Doppler findings, while 
six (31.5%) showed variations 2 15% of Doppler haemo- 
dynamic parameters during NPPV plus 0, when compared 
with 0, therapy alone. Four of these patients experienced 
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TABLE 2. Patients’ measurements during 0, supplementation and after 30 min of NPPV (mean * SD) 
Parameters O2 alone 0, + NPPV P value 
PH 7.25 f 0.09 7.32 5 0.05 <0.001* 
PaO, (kPa) 8.71 I!I 1.11 8.75 rt 1.01 0.870 
PaCO, (kPa) 10.25 * 1.76 8.57 k 1.09 <0.001* 
RR (breaths min - ‘) 30 * 7 25 f 3 <0.001* 
Mean BP (mmHg) 109.58 f 21.97 104.68 zt 13.45 0.134 
Systolic BP (mmHg) 150.25 zk 31.27 141.50 f 19.74 0.064 
HR (beats min - ‘) 100.42 f 16.09 97.84 I’C 16.35 0.265 
PAMP (mmHg) 37.27 ?c 5.38 35.63 f 5.30 0.298 
AcT/RVET 0.38 * 0.04 0.40 f 0.06 0.089 
PASP (mmHg) 59.27 f 13.83 55.89 f 13.26 0.063 
CO (1 min - ‘) 6.59 f 1.93 6.65 f 2.03 0.829 
CI (lmin’m-‘) 3.53 f 0.86 3.56 zk 0.97 0.851 
*Statistically significant. 
TABLE 3. Patients showing changes of 2 15% in echocardiographic haemodynamic measurements after 30 min of NPPV 
administration plus 0, 
Patient 
no. 
CI Systolic Diastolic HR RR 
PASP PAMP (1 min - ’ BP BP (beats (breaths Mask PaCO, 
(mmHg) (mmHg) kg - ’ m -‘) (mmHg) (mmHg) min ~ ‘) min- ‘) tolerance (kPa) pH 
110 70 102 32 
115 85 100 34 
145 80 119 30 
140 80 113 26 
Poor 
10.26 7.29 
8.24 7.35 
3 02 82 47.5 
3 0, + NPPV 82 45 
2.85 
2.25 
(- 21%) 
4.5 
3.5 
( - 22%) 
4.55 
.5.76 
(+26%) 
4.3 
3.57 
(- 17%) 
2.39 
(+33;%) 
4.23 
3.63 
(-15%) 
5 02 NA 
5 O,+NPPV NA Good 
11.91 7.17 
7.84 7.33 
43 
(-324%) 
43 
39 
150 90 86 30 
150 90 110 28 Good 
10.1 7.19 
8.67 7.29 
602 
6 0, + NPPV 
78 
(-5%) 
NA 
NA 
10 0, 
10 O,+NPPV 
32 
(5%) 
43 
43 
150 80 99 48 
160 90 91 36 Poor 
13.73 7.15 
10.46 7.25 
11 0, 60.4 
11 O,+NPPV 61 
160 90 110 34 
140 80 82 26 Good 
11.67 7.22 
8.28 7.34 
130 80 125 28 
140 80 108 32 Poor 
11.1 7.29 
9.17 7.34 
14 0, 
14 O,+NPPV 
45 
37.3 
(- 18%) 
NA 
NA 
NA, not assessed. 
consistent decreases in cardiac output, although cardiac 
output increased for the remaining two. Moreover, four 
patients showed a significant reduction of PASP and/or 
PAMP. Table 3 shows data for patients who had PAP 
and/or CI changes 2 15% during NPPV. No correlation 
was found between decreased CO and baseline data. Con- 
versely, three patients showing CO reduction had poor 
tolerance to mask ventilation and did not improve RR 
during NPPV. All the remaining patients showed good 
compliance with mask ventilation. All but two patients 
(1709) had a successful outcome with NPPV therapy 
(success rate 89.5%). 
REPEATABILITY AND FEASIBILITY OF DOPPLER 
MEASUREMENTS 
Both intraobserver and interobserver variability for 
PASP, PAMP and CI was less than 6%. One or more 
haemodynamic parameters were obtained by Doppler 
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echocardiography in most of the patients (16/18=89,5X 
of the study population). Tricuspid regurgitation was 
detected in 570/u, though Doppler recording quality was 
adequate for velocity measurements in 47%. Pulmonary 
flow velocity profiles were obtained from 12 of the 19 
COPD patients (63%). Also, tracings of these 12 patients 
sufficed for mPAP evaluation. Determination of cardiac 
output was possible in 89% of subjects. 
Discussion 
Initiation of invasive mechanical ventilation by endo- 
tracheal intubation may cause alteration of haemodynam- 
its, especially in patients with AVF, because of acute 
exacerbation of COPD (6,36). In this clinical setting, a 
reduction in systemic venous return, the administration of 
sedative drugs before intubation and the effects of pro- 
gressive hyperinflation-auto-PEEP and fluid depletion are 
considered to be the major contributors to hypotension 
(5,6,37,38). Recently, NPPV has been introduced as an 
alternative to endotracheal intubation in severe exacer- 
bation of COPD (39,40). Although NPPV is widely used 
for patients with COPD and AVF, no mention of negative 
haemodynamic effects of NPPV appears in the English 
language literature (4,41). 
In the present study, we show that, during the initiation 
of NPPV, some haemodynamic alteration may take place in 
individual COPD patients with AVF, In fact, four patients 
(21%) showed reduction of cardiac index during NPPV. It 
is worth noting that no patients had hypotension during 
NPPV administration. Indeed, NPPV application did not 
significantly change haemodynamics in most of our study 
population and, after 30 min of NPPV, the main haemo- 
dynamic data (cardiac output and cardiac index, pulmonary 
and systemic blood pressures) remained stable in 13 patients 
(68.4%). Moreover, arterial pH and PaCO, improved 
significantly during NPPV administration in all patients. 
The maintenance of normal CO after 30 min of NPPV 
in the majority of the patients was not due to an increase in 
heart rate, as this remained stable or decreased. Also, in 
patients showing decreases of CO during NPPV, no corre- 
lation was found with baseline data. Nevertheless, three of 
these patients showed a poor tolerance to mask ventilation, 
as was, also confirmed by stable or increased RR. A lack 
of synchrony with ventilatory interface and consequent 
increased RR may have contributed to single patients 
developing increased hyperinflation and auto-PEEP (42). 
Furthermore, auto-PEEP is known to lead to decreased 
venous return and reduced CO (9). A change in stroke 
volume and/or peripheral resistance could be the mechan- 
ism behind the decrease in CI, but the lack of hypotension 
showed that in any case there were no important clinical 
consequences. Nevertheless, in AVF the Cl is often elevated 
because of increased oxygen demand by the respiratory 
muscles and a drop in the CI value sometimes might 
represent an improvement, whereas an increase in CI might 
actually mean that the patient is working harder and 
needing more 0, delivered (13,14). Since cardiopulmonary 
interactions during positive pressure ventilation are com- 
plex, we cannot exclude the possibility that fluid depletion 
levels might have influenced CO reduction in some patients. 
With regard to pulmonary circulation, at baseline pul- 
monary hypertension was observed in all the patients, but 
none of our 19 patients increased pulmonary pressures 
during NPPV, although in four cases a relevant reduction 
of PAP occurred. 
To our knowledge, this study is the first that evaluates the 
haemodynamics of NPPV in COPD patients with AVF. 
Ambrosino et ul. (43) reported haemodynamics data 
obtained through invasive methods performed on COPD 
patients in a clinically stable condition. Ambrosino et al. 
(43) found a significant fall in CO only when an external 
PEEP of 5 cmH,O was administered. Nevertheless, patients 
with AVF due to severe exacerbation of COPD generally 
have higher auto-PEEP than those in a stable condition 
(44). Thus, the administration of equal levels of external 
PEEP may counterbalance or increase auto-PEEP if 
provided in acute or stable clinical settings (23.42). 
We found that Doppler echocardiography is a well- 
tolerated, efficient evaluation method that can be used at 
NPPV initiation in acute COPD patients. It is well known 
that ultrasound examination of the heart is technically 
difficult in patients with hyperinflation of the lungs (45). 
However, expert and motivated echocardiograph tech- 
nicians can obtain suitable images in up to 80-97X of 
patients (46,47). In our experience, the subcostal approach 
successfully detected adequate Doppler signals in a large 
proportion of COPD patients, thus confirming the results 
of Tramarin et al. (48). 
In conclusion, our study suggests that the initiation of 
NPPV is haemodynamically safe for most patients with 
exacerbated COPD and AVF, although individual COPD 
patients with AVF may experience reduction in CI in spite 
of adequate levels of oxygen saturation during initiation of 
NPPV by facial mask. This event may be associated with 
patient inability to synchronize with mask ventilation. 
Consequently, we strongly suggest that particular caution 
should be used when applying NPPV with predetermined 
and fixed pressures since a decrease in CO may occur in 
patients who are hypotensive or have low fluid volume. In 
addition, to maximize mask ventilation tolerance, attempts 
to optimize EPAP and IPAP are preferable to scheduled 
ventilatory support settings. Finally, we recommended 
Doppler echocardiography as a useful tool for early detec- 
tion of haemodynamic alterations due to NPPV application 
in patients with AVF. 
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